In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values

BACKGROUND: At present, the clinical breakpoints (CBPs) of both fluconazole and voriconazole are available only for 3 common Candida species in the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methods. Epidemiological...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jang, Min Joong, Shin, Jong Hee, Lee, Wee Gyo, Kim, Mi-Na, Lee, Kyungwon, Lee, Hye Soo, Lee, Mi-Kyung, Chang, Chulhun L., Jang, Hee-Chang, Song, Eun Song, Kim, Soo Hyun, Shin, Myung-Geun, Suh, Soon-Pal, Ryang, Dong-Wook
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Society for Laboratory Medicine 2013
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646190/
https://ncbi.nlm.nih.gov/pubmed/23667842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2013.33.3.167
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы